NCT01424332View on ClinicalTrials.gov

To Evaluate Whether Acetyl Salicylic Acid (Aspirin) and Darexaban (YM150) Interact in Their Effects

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Pharmacodynamic and Pharmacokinetic InteractionHealthy Subjects
Interventions
DRUG

Darexaban

oral

DRUG

Acetyl Salicylic Acid (ASA)

oral

Trial Locations (1)

75015

SGS Aster, Paris

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT01424332 - To Evaluate Whether Acetyl Salicylic Acid (Aspirin) and Darexaban (YM150) Interact in Their Effects | Biotech Hunter | Biotech Hunter